High Quality CAS 141732-76-5 Exenatide Acetate Peptide

High Quality CAS 141732-76-5 Exenatide Acetate Peptide

Min.Order / FOB Price:Get Latest Price

1 Gram	FOB Price: USD 15.0000

1 Gram

FOB Price: USD 15.0000

Min.Order :1 Gram
Purity: 99%
Payment Terms : T/T,Other

Keywords

Peptides Pharmaceutical Intermediate Chemical

Quick Details

Appearance:White Powder
Application:bodybuilding pharmaceutical material, Steroid hormone, Anabolin. As a male hormone and anabolic hormones.
PackAge:Packaging can be according to customer
ProductionCapacity:10000|Metric Ton|Day
Storage:Keep it under seal in cool and dark place
Transportation:FEDEX DHL TNT UPS EUB

Superiority:

This is Allen from Zhengzhou Filter Biotechnology Co.,Ltd.We are the professional supplier of peptide products in China over 10 years. we have Professional Lab to confirm the Quality and Serive for all clients in long-term run cooperation.
Our Company as a Pharmaceutical Raw Material Manufacturer specialize in R&D the New Drugs and Producing the Generic Medicine:

Amino Acids&Vitamins
Pharmaceutical Polypeptide,
Comestic Polypeptide,
Veterinary Peptide and
Pharmaceutical APIs.
Due to of the high quality and good service, They have been exported more than 30 countries.
Sincerely hope to have a chance to cooperate with you

Details:

Description

Name:Eptifibatide Acetate, eptifibatida, Eptifibatid
Cas No:148031-34-9
Formula: C37H53N11O11S2
Molecular:892
Sequence:3-MERCAPTOPROPIONYL-HOMOARG-GLY-ASP-TRP-PRO-CYS-NH2 ACETATE SALT (DISULFIDE BOND)
Purity:98%
Appearance: white powder
Source: synthetic
Also known as: Intrifiban,INTEGRILIN ACETATE, CHEBI:291902 ACETATE, 3-MERCAPTOPROPIONYL-HOMOARG-GLY-ASP-TRP-PRO-CYS-NH2 ACETATE, 3-MERCAPTOPROPIONYL-HOMOARG-GLY-ASP-TRP-PRO-CYS-NH2 ACETATE SALT (DISULFIDE BOND)
.Introduction :
Exenatide is a glucagon-like peptide-1 agonist (GLP-1 agonist) medication, belonging to the group of incretin mimetics, approved in April 2005 for the treatment of diabetes mellitus type 2. Exenatide in its Byetta form is administered as a subcutaneous injection (under the skin) of the abdomen, thigh, or arm, any time within the 60 minutes before the first and last meal of the day.A once-weekly injection has been approved as of January 27, 2012 under the trademark Bydureon. It is manufactured by Amylin Pharmaceuticals and commercialized by Astrazeneca.

View All

Visit Store